RNASEK Is a V-ATPase-Associated Factor Required for Endocytosis and the Replication of Rhinovirus, Influenza A Virus, and Dengue Virus

Cell Reports

Volumn 12, Issue 5, 2015, Pages 850-863

  Perreira, Jill M ^a   Aker, Aaron M ^a   Savidis, George ^a   Chin, Christopher R ^a   McDougall, William M ^a   Portmann, Jocelyn M ^a   Meraner, Paul ^a   Smith, Miles C ^a   Rahman, Motiur ^a   Baker, Richard E ^a   Gauthier, Annick ^b   Franti, Michael ^b   Brass, Abraham L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CLATHRIN; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 2; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; POLYPROTEIN; PROTON PUMP; RIBONUCLEASE; RNA; UNCLASSIFIED DRUG; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RIBONUCLEASE K;

5' UNTRANSLATED REGION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DENGUE VIRUS; DISEASE EXACERBATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; PATHOGENICITY; PRIORITY JOURNAL; RECEPTOR BINDING; RHINOVIRUS; RNA INTERFERENCE; UPPER RESPIRATORY TRACT INFECTION; VESICULAR STOMATITIS; VIRUS CAPSID; VIRUS GENOME; VIRUS REPLICATION; VIRUS VIRULENCE; GENETICS; HELA CELL LINE; INFLUENZA A VIRUS; METABOLISM; PHYSIOLOGY;

DENGUE VIRUS; HUMAN RHINOVIRUS SP.; INFLUENZA A VIRUS; RHINOVIRUS;

DENGUE VIRUS; ENDOCYTOSIS; ENDORIBONUCLEASES; HELA CELLS; HUMANS; INFLUENZA A VIRUS; RHINOVIRUS; VACUOLAR PROTON-TRANSLOCATING ATPASES; VIRUS REPLICATION;

EID: 84938551448     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.06.076     Document Type: Article

References (29)

1. Adamson B., Smogorzewska A., Sigoillot F.D., King R.W., Elledge S.J. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat. Cell Biol. 2012, 14:318-328.
2. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
3. Buehler E., Chen Y.C., Martin S. C911: A bench-level control for sequence specific siRNA off-target effects. PLoS ONE 2012, 7:e51942.
4. Che Z., Olson N.H., Leippe D., Lee W.M., Mosser A.G., Rueckert R.R., Baker T.S., Smith T.J. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes. J. Virol. 1998, 72:4610-4622.
5. Cherry S., Doukas T., Armknecht S., Whelan S., Wang H., Sarnow P., Perrimon N. Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 2005, 19:445-452.
6. Cherry S., Kunte A., Wang H., Coyne C., Rawson R.B., Perrimon N. COPI activity coupled with fatty acid biosynthesis is required for viral replication. PLoS Pathog. 2006, 2:e102.
7. Dehay B., Martinez-Vicente M., Ramirez A., Perier C., Klein C., Vila M., Bezard E. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 2012, 8:1389-1391.
8. Dehay B., Ramirez A., Martinez-Vicente M., Perier C., Canron M.H., Doudnikoff E., Vital A., Vila M., Klein C., Bezard E. Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. USA 2012, 109:9611-9616.
9. Echeverri C.J., Beachy P.A., Baum B., Boutros M., Buchholz F., Chanda S.K., Downward J., Ellenberg J., Fraser A.G., Hacohen N., et al. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods 2006, 3:777-779.
10. Economopoulou M.A., Fragoulis E.G., Sideris D.C. Molecular cloning and characterization of the human RNase kappa, an ortholog of Cc RNase. Nucleic Acids Res. 2007, 35:6389-6398.
11. Feeley E.M., Sims J.S., John S.P., Chin C.R., Pertel T., Chen L.M., Gaiha G.D., Ryan B.J., Donis R.O., Elledge S.J., Brass A.L. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 2011, 7:e1002337.
12. Feng H., Cheng T., Pavlos N.J., Yip K.H., Carrello A., Seeber R., Eidne K., Zheng M.H., Xu J. Cytoplasmic terminus of vacuolar type proton pump accessory subunit Ac45 is required for proper interaction with V(0) domain subunits and efficient osteoclastic bone resorption. J. Biol. Chem. 2008, 283:13194-13204.
13. Fuchs R., Blaas D. Productive entry pathways of human rhinoviruses. Adv. Virol. 2012, 2012:826301.
14. Hiesinger P.R., Fayyazuddin A., Mehta S.Q., Rosenmund T., Schulze K.L., Zhai R.G., Verstreken P., Cao Y., Zhou Y., Kunz J., Bellen H.J. The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 2005, 121:607-620.
15. Jansen E.J., Holthuis J.C., McGrouther C., Burbach J.P., Martens G.J. Intracellular trafficking of the vacuolar H+-ATPase accessory subunit Ac45. J. Cell Sci. 1998, 111:2999-3006.
16. Jansen E.J., van Bakel N.H., Olde Loohuis N.F., Hafmans T.G., Arentsen T., Coenen A.J., Scheenen W.J., Martens G.J. Identification of domains within the V-ATPase accessory subunit Ac45 involved in V-ATPase transport and Ca2+-dependent exocytosis. J. Biol. Chem. 2012, 287:27537-27546.
17. John S.P., Chin C.R., Perreira J.M., Feeley E.M., Aker A.M., Savidis G., Smith S.E., Elia A.E., Everitt A.R., Vora M., et al. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J. Virol. 2013, 87:7837-7852.
18. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225-1229.
19. Kirchhausen T., Owen D., Harrison S.C. Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb. Perspect. Biol. 2014, 6:a016725.
20. Kiritsi M.N., Fragoulis E.G., Sideris D.C. Essential cysteine residues for human RNase κ catalytic activity. FEBS J. 2012, 279:1318-1326.
21. Kozik P., Hodson N.A., Sahlender D.A., Simecek N., Soromani C., Wu J., Collinson L.M., Robinson M.S. A human genome-wide screen for regulators of clathrin-coated vesicle formation reveals an unexpected role for the V-ATPase. Nat. Cell Biol. 2013, 15:50-60.
22. Luo B., Cheung H.W., Subramanian A., Sharifnia T., Okamoto M., Yang X., Hinkle G., Boehm J.S., Beroukhim R., Weir B.A., et al. Highly parallel identification of essential genes in cancer cells. Proc. Natl. Acad. Sci. USA 2008, 105:20380-20385.
23. Marshansky V. The V-ATPase a2-subunit as a putative endosomal pH-sensor. Biochem. Soc. Trans. 2007, 35:1092-1099.
24. Marshansky V., Rubinstein J.L., Grüber G. Eukaryotic V-ATPase: novel structural findings and functional insights. Biochim. Biophys. Acta 2014, 1837:857-879.
25. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., Maccallum P., Meade T.W., Jeffries D.J., Johnston S.L., Wedzicha J.A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001, 164:1618-1623.
26. Simmonds P., McIntyre C., Savolainen-Kopra C., Tapparel C., Mackay I.M., Hovi T. Proposals for the classification of human rhinovirus species C into genotypically assigned types. J. Gen. Virol. 2010, 91:2409-2419.
27. Subtil A., Gaidarov I., Kobylarz K., Lampson M.A., Keen J.H., McGraw T.E. Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc. Natl. Acad. Sci. USA 1999, 96:6775-6780.
28. Supek F., Supekova L., Mandiyan S., Pan Y.C., Nelson H., Nelson N. A novel accessory subunit for vacuolar H(+)-ATPase from chromaffin granules. J. Biol. Chem. 1994, 269:24102-24106.
29. Tacheva-Grigorova S.K., Santos A.J., Boucrot E., Kirchhausen T. Clathrin-mediated endocytosis persists during unperturbed mitosis. Cell Rep. 2013, 4:659-668.